CervoMed (CRVO) Preferred Dividend Payments (2013 - 2018)
CervoMed (CRVO) posted Preferred Dividend Payments of $85993.0 for Q1 2018, down 74.67% sequentially from $339448.0 in Q4 2017, and up 46.13% YoY from $58845.0 in Q1 2017.
CervoMed (CRVO) Preferred Dividend Payments (2013 - 2018) Analysis & Trends
CervoMed has reported Preferred Dividend Payments for 3 years, with the latest figure at $85993.0 in Q1 2018.
- Quarterly Preferred Dividend Payments rose 46.13% year-over-year to $85993.0 in Q1 2018, while the trailing twelve-month figure through Dec 2018 was $85993.0 (down 93.13% YoY) and the FY2018 annual result came in at $85993.0, down 93.13% from the prior year.
- Preferred Dividend Payments slipped to $85993.0 in Q1 2018 per CRVO's latest filing, from $339448.0 in the prior quarter.
- Over five years, Preferred Dividend Payments peaked at $487460.0 in Q2 2017 and troughed at $58845.0 in Q1 2017.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | CervoMed | 26.64 Mn | 26.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 85,993.00 |
| Dec 31, 2017 | 339,448.00 |
| Sep 30, 2017 | 366,641.00 |
| Jun 30, 2017 | 487,460.00 |
| Mar 31, 2017 | 58,845.00 |
| Jun 30, 2013 | 47,250.00 |